港股早評:三大指數大幅低開 科技股、汽車股普跌 税收政策調整內房股大升
隔夜美股三大指數升跌不一,熱門中概股多數下跌。昨日止跌的港股再度低開,恒指跌0.99%,國指跌1.18%,恒生科技指數跌1.51%。盤面上,大型科技股集體下跌,美團跌2.5%,京東跌近2%,網易跌1.66%,快手、阿里巴巴跌1.5%,小米、百度、騰訊均下跌;汽車股普遍下跌,小鵬汽車跌近3%,理想汽車、吉利汽車、長城汽車跌超1%;濠賭股、消費電子股、體育用品股、家電股、蘋果概念股普跌。另一方面,多項税收政策調整,利好房地產市場,內房股集體上升,富力地產大升10%,融創中國、世茂集團升超5%,鋰電池股、軟件類股、紙業股多數逆勢上升,權重贛鋒鋰業升2.5%。(格隆匯)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.